B-Raf mutations are associated with a worse outcome in ovarian cancer

被引：0
|
作者：
Libra, Massimo [1 ]
Russo, Alessia E. [1 ]
Pellizzari, Ilenia [2 ]
Bagnoli, Marina [3 ]
Raspagliesi, Francesco [4 ]
Sorio, Roberto [5 ]
Baldassarre, Gustavo [2 ]
Canevari, Silvana [3 ]
机构：
[1] Univ Catania, Dept Biomed Sci, Catania, Italy
[2] Natl Canc Inst, Ctr Riferimento Oncol, Div Expt Oncol 2, Aviano, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Expt Oncol & Mol Med Dept, Unit Mol Therapies, Milan, Italy
[4] IRCCS Ist Nazl Tumori, Dept Gynecol Oncol, Milan, Italy
[5] IRCCS, Natl Canc Inst, Unit Med Oncol C, Aviano, Italy
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
332
引用
收藏
页数：1
相关论文
共 50 条
  • [31] RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer
    Pijnenborg, J. M. A.
    Veen, G. C. Dam-de
    Kisters, N.
    Delvoux, B.
    van Engeland, M.
    Herman, J. G.
    Groothuis, P. G.
    ANNALS OF ONCOLOGY, 2007, 18 (03) : 491 - 497
  • [32] B-RAF and melanocytic neoplasia
    Gill, M
    Celebi, JT
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (01) : 108 - 114
  • [33] Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF
    Emuss, V
    Garnett, M
    Mason, C
    Marais, R
    CANCER RESEARCH, 2005, 65 (21) : 9719 - 9726
  • [34] Mechanisms of B-RAF mediated oncogenesis in human cancer.
    Marais, R
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9179S - 9179S
  • [35] MEK1 mutations confer resistance to MEK and B-RAF inhibition
    Emery, Caroline M.
    Vijayendran, Krishna G.
    Zipser, Marie C.
    Sawyer, Allison M.
    Niu, Lili
    Kim, Jessica J.
    Hatton, Charles
    Chopra, Rajiv
    Oberholzer, Patrick A.
    Karpova, Maria B.
    MacConaill, Laura E.
    Zhang, Jianming
    Gray, Nathanael S.
    Sellers, William R.
    Dummer, Reinhard
    Garraway, Levi A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) : 20411 - 20416
  • [36] B-RAF V600E AND B-RAF CODON 464-469 MUTATIONS IN HAIRY CELL LEUKEMIA PATIENTS AND THEIR RELATION WITH CLINICAL PARAMETERS
    Olgun, Aybuke
    Basbinar, Yasemin
    Alacacioglu, Inci
    Solmaz, Serife
    Akbarpour, Mahdi
    Kilic, Tugba U. Y. S. A. L.
    Birge, Ozlem
    Ozkal, Sermin
    Ellidokuz, Hulya
    Ozcan, Mehmet Ali
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2021, 5 (03): : 1 - 6
  • [37] Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif
    Moretti, Sonia
    De Falco, Valentina
    Tamburrino, Anna
    Barbi, Flavia
    Tavano, Maria
    Avenia, Nicola
    Santeusanio, Fausto
    Santoro, Massimo
    Macchiarulo, Antonio
    Puxeddu, Efisio
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (11): : 1634 - 1645
  • [38] B-Raf mutation: A key player in molecular biology of cancer
    Rahman, M. A.
    Salajegheh, A.
    Smith, R. A.
    Lam, A. K. -Y.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 95 (03) : 336 - 342
  • [39] Fotemustine (F) in the treatment of malignant melanoma nonassociated with B-RAF mutations.
    Svetitskaya, Yana V.
    Vladimirova, Liubov Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] B-RAF is a therapeutic target in melanoma
    Karasarides, M
    Chiloeches, A
    Hayward, R
    Niculescu-Duvaz, D
    Scanlon, I
    Friedlos, F
    Ogilvie, L
    Hedley, D
    Martin, J
    Marshall, CJ
    Springer, CJ
    Marais, R
    ONCOGENE, 2004, 23 (37) : 6292 - 6298
12345